NRG-BR002 for Oligometastatic Breast Cancer - Clinical Trial
What is the Purpose of this Study?
We are doing this study to compare any good or bad effects of delivering ablative local therapy to ALL known metastatic tumor sites, (even those that are not causing symptoms); in addition to the usual approach of intravenous or oral medications for treatment of breast cancer that has spread up to 4 body sites.
Oligometastatic Breast Cancer
Who Can Participate in the Study?
Adult women with breast cancer which has spread who:
- Are not pregnant or nursing
What is Involved?
If you agree to be in the study, you will:
- Be randomized (put into one of two groups by chance like a flip of a coin) and receive either:
Group 1 - usual treatment for metastatic breast cancer which is oral or intravenous medications and may include surgery, radiation, and other methods.
Group 2 - receive the usual treatment for metastatic breast cancer which is oral or intravenous medications PLUS ablative local therapy (SBRT or surgical resection) to all known metastatic sites.